The importance of changes in blood analysis in the diagnostics of excitation of ischemic heart disease

  • V.O. Romanova
  • V.K. Serkova
  • S.V. Shershun
Keywords: stable coronary heart disease, unstable angina, inflammation at atherosclerosis, leukocyte formula, C-reactive protein, fibrinogen.


The purpose of the study: the determination of the significance of blood test parameters in the diagnosis of atherosclerosis and coronary heart disease in order to prevent the activation of the atherothrombogenesis process. The results of the survey of 135 patients with coronary heart disease are summarized. There are 94 men and 41 women (mean age 57,24±5,12 years), including 92 patients with stable coronary heart disease and 43 with unstable (progressive) angina. The differences in complete and biochemical blood tests in patients with stable and unstable course of the process are revealed. It is noted that changes in the complete blood count and increase in the C-reactive protein and fibrinogen levels are associated with the atherosclerosis phase, its exacerbations and remissions periods, the degree of the vessels involvement in the inflammation and, to a lesser extent, the arterial hypertension presence.


1. Antomonov, M. Yu. (2006). Matematicheskaya obrabotka i analiz mediko-biologicheskih dannyh. Kyiv: „Malyi druk”. [in Russian].

2. Bratus, V. V., & Talaeva, T. V. (2007). Vospalenie kak patogeneticheskaya osnova ateroskleroza. Ukrainskyi kardiolohichnyi zhurnal, 1, 90–96. [in Russian].

3. Lutaj, M. I., Golikova, I. P., & Deyak, S. I. (2006). Sistemnoe vospalenie u pacientov s ishemicheskoj boleznyu serdca: vzaimosvyaz s klinicheskim techeniem i nalichiem faktorov riska. Ukrainskyi medychnyi chasopys, 2(52), 80–83. [in Russian].

4. 2013 ESC guidelines on the management of stable coronary artery disease. (2013). European Heart Journal, 34(38), 2949–3003. doi:10.1093/eurheartj/eht296.

5. Anogeianaki, A., Angelucci, D., Cianchetti, E., Dalessandro, M., Maccauro, G., Saggini, A., ... Shaik-Dasthagirisaheb, Y. (2011). Atherosclerosis: A Classic Inflammatory Disease. International Journal of Immunopathology and Pharmacology, 24(4), 817–825. doi:10.1177/039463201102400401.

6. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. (2010). The Lancet, 375(9709), 132–140. doi:10.1016/s0140-6736(09)61717-7.

7. Devaraj, S., Singh, U. & Jialal, I. (2008). The Evolving Role of C-Reactive Protein in Atherothrombosis. Clinical Chemistry, 55(2), 229–238. doi:10.1373/clinchem.2008.108886.

8. Dragu, R., Huri, S., Zuckerman, R., Suleiman, M., Mutlak, D., Agmon, Y., ... Aronson, D. (2008). Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis, 196(1), 405–412. doi:10.1016/j.atherosclerosis.2006.11.022.

9. Gach, O., Nys, M., Deby-Dupont, G., Chapelle, J., Lamy, M., Piérard, L. A. & Legrand, V. (2006). Acute neutrophil activation in direct stenting: Comparison of stable and unstable angina patients. International Journal of Cardiology, 112(1), 59–65. doi:10.1016/j.ijcard.2005.09.010.

10. Hansson, G. K., & Hermansson, A. (2011). The immune system in atherosclerosis. Nature Immunology, 12(3), 204–212. doi:10.1038/ni.2001.

11. Horne, B. D., Anderson, J. L., John, J. M., Weaver, A., Bair, T. L., Jensen, K. R. ... Muhlestein, J. B. (2005). Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk? Journal of the American College of Cardiology, 45(10), 1638–1643. doi:10.1016/j.jacc.2005.02.054.

12. Imano, H., Sato, S., Kitamura, A., Kiyama, M., Ohira, T., Shimamoto, T. & Iso, H. (2007). Leukocyte count is an independent predictor for risk of acute myocardial infarction in middle-aged Japanese men. Atherosclerosis, 195(1), 147–152. doi:10.1016/j.atherosclerosis.2006.09.002.

13. Packard, R. R. & Libby, P. (2007). Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clinical Chemistry, 54(1), 24–38. doi:10.1373/clinchem.2007.097360.

14. Ridker, P. M. (2016). Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. European Heart Journal, 37(22), 1720–1722. doi:10.1093/eurheartj/ehw024.

15. Yarnell, J. & McCrum, E. (2005). Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study. European Heart Journal, 26(4), 332–342. doi:10.1093/eurheartj/ehi052.
How to Cite
Romanova, V., Serkova, V., & Shershun, S. (2017). The importance of changes in blood analysis in the diagnostics of excitation of ischemic heart disease. Reports of Vinnytsia National Medical University, 21(2), 453-456. Retrieved from